Ron Eastman, Mba

Biography

Mr. Eastman, Managing Director of Essex Woodlands, has over 30 years of experience in building healthcare businesses. Mr. eastman began his career at American Cyanamid Company, where he spent 15 years managing pharmaceutical products, divisions and subsidiaries in the U.S. and overseas. Since then, Mr. Eastman has helped build three private healthcare companies - Geron, HCORP, and Rinat Neuroscience. Under his leadership, Geron became a cutting-edge biotech company which grew from a venture-backed startup to a publicly traded pioneer in the fields of regenerative medicine and cancer.  HCORP quickly established itself as the technology and market leader in the emerging field of hospital-based, interactive patient services and was sold to a diversified competitor. At Rinat, Mr. Eastman led the effort to build the first company dedicated to discovering and developing large molecule drugs for treating nervous system disorders.  Rinat was acquired by Pfizer for $500M in 2006. Mr. Eastman serves on the boards of Corium International, EluSys Therapeutics, Inc., IntegenX Inc., Open Monoclonal Technology, Inc. ("OMT"), Protein Simple and Revance Therapeutics, Inc. He holds a Bachelor of Arts from Williams College and a Master of Business Administration degree from Columbia University. Mr. Eastman serves as a member of Symphogen's Remuneration Committee. 

Research Interest

 clinical-stage antibody oncology-focused research